Home > Services > Biobank: Introduction and portfolio of services

Biobank

Biobanco
Head of Unit: Manuel M. Morente

Information for researches: introduction and portfolio of services

Introduction:

The National Cancer Research Centre Biobank (CNIO-Biobank) is established as a cross-service platform for CNIO researchers and the scientific community in general.

CNIO Biobank is, as defined by the Spanish Law 14/2007 on biomedical research, and Royal Decree RD 1716/2011, a "Biobank for biomedical research purposes".

As such it is defined as a public, non-profit organisation which hosts several collections of human biological samples to be used for biomedical research; it is organised as a technical unit with strict criteria of quality, order and purpose, independently of hosting other collections of biological samples for different purposes.

Portfolio of services:

The Biobank legal Scheme:
  • Collection, management, manipulation and custody of human biological samples and associated documentation, all under the scope of the Biobank legal scheme.
  • Transfer of samples and clinical biomedical information to research projects, under the approval of the corresponding scientific and ethical committees.
Management of other collections
  • Custody service of collections of biological samples and / or information related to biomedical research promoted by CNIO or other external research groups.
  • Coordination of sample collections in multicentre studies.
  • Processing of products derived from human samples for research (tissue arrays, DNA, RNA, etc...).
  • Researchers who want to deposit their collections at CNIO-Biobank facilities or request samples must sign an MTA (Material Transfer Agreement) which specifies the terms and conditions under which the Biobank will custody samples and data.
Ethical-legal advice concerning the use of human samples in biomedical research
  • Technical, scientific and ethical advice regarding the collection, storage and management of human samples used for biomedical research as well as in the creation and management of new collections that are out of the scope of the Biobank; in accordance with the present Spanish legal framework.
  • Collaboration and advising in the design and interpretation of immunohistochemical studies.
  • Quality Management Programme.